Oswaldo Bernal from Bristol Myers Squibb: Innovation in Oncology with AI
Oswaldo Bernal shares Bristol Myers Squibb's vision on using AI in oncology.
by Jose Zea•1 min read
Oswaldo Bernal from Bristol Myers Squibb
Laura Velásquez from Arkangel AI speaks with Oswaldo Bernal about how Bristol Myers Squibb is using AI to advance cancer treatment.
Episode Summary
- Guest: Oswaldo Bernal
- Company: Bristol Myers Squibb
- Topics: Oncology, drug development, immuno-oncology, clinical research
- Why it matters: Bristol Myers Squibb is a leader in oncology treatments and their AI adoption impacts the development of new therapies.
About Arkangel AI
Arkangel AI is accelerating the adoption of artificial intelligence in healthcare across Latin America, connecting technology, clinical expertise, and practical implementation to transform medical care.